Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non–vitamin K antagonist oral anticoagulants

Kazuo Miyazawa; Daniele Pastori; Professor Gregory Lip

doi:10.1016/j.ahj.2017.11.015

Back

Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non–vitamin K antagonist oral anticoagulants

Editorial Material 2018 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation

Myung‐Jin Cha, Eue-Keun Choi, Kyungdo Han, So-Ryoung Lee, Woo‐Hyun Lim, Seil Oh, Professor Gregory Lip

Article2021

Comparative Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients

Wengen Zhu, Zi Ye, Shilan Chen, Dexi Wu, Jiangui He, Yugang Dong, Professor Gregory Lip, Chen Liu

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function

Seil Oh, Professor Gregory Lip, So-Ryoung Lee, Eue-Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha

Article2018

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy

Hyunjean Jung, Pil‐Sung Yang, Eunsun Jang, Hee Tae Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Professor Gregory Lip

Article2017

Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy

N. Bennaghmouch, A. J. W. M. de Veer, Kerstin Bode, Bakhtawar K. Mahmoodi, Willem J.M. Dewilde, Professor Gregory Lip, Martina Brueckmann, Eva Kleine, Jurriën M. ten Berg